-
Merck Announces Phase 3 KEYNOTE-522 Trial Met its Overall Survival (OS) Endpoint in Patients With High-Risk Early-Stage Triple Negative Breast Cancer (TNBC)
28 May 2024 11:03 GMT
… drug conjugate that Merck is developing in collaboration with Kelun-Biotech … our portfolio of medicines and pipeline … thalidomide analogue plus dexamethasone resulted in increased mortality. Treatment … the impact of pharmaceutical industry regulation and …
-
Advancements and Ethical Considerations in Clinical Trials
27 May 2024 08:08 GMT
… ensuring voluntary participation. The Thalidomide tragedy in the early … gain access to post-trial treatment is very dynamic.
In … the Drug Controller and the New Drugs and Clinical Trials Rules … In addition to improving medical practice, clinical research aims …
-
Thalidomide victims receive first compensation payment from near €1 million fund
22 May 2024 14:41 GMT
… be done by an independent medical board which received 40 … that in the sixties, thalidomide pills were normally prescribed for pregnant … morning sickness and despite the drug being prohibited internationally in … . She added that this drug was the cause of a …
-
Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
21 May 2024 11:20 GMT
… . Food and Drug Administration (FDA) has reassigned … frontiers in personalized medicine and, through … thalidomide analogue plus dexamethasone resulted in increased mortality. Treatment … and commercialization of pharmaceutical products. All statements …
-
Raymond Thertulien, MD, PhD, on How Abnormalities Drive Treatment Choices in Multiple Myeloma
20 May 2024 14:03 GMT
… and dexamethasone], VTD [bortezomib, thalidomide, and dexamethasone]. All these … CD38 plus 3 other drugs, and currently the … findings from] the German trials that have been presented … trial of lenalidomide, bortezomib, dexamethasone vs high-dose treatment …
-
Sixty years on, the state must settle with thalidomide survivors
19 May 2024 00:46 GMT
… their issue is ever sorted, thalidomide survivors will surely hold the … the international withdrawal of the drug that caused such devastating damage … have been bittersweet for the thalidomide group as they watched the …
-
Merck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline
15 May 2024 10:55 GMT
… drug conjugate (ADC) being developed in collaboration with Kelun-Biotech … in the confirmatory trials.
KEYTRUDA, in … thalidomide analogue plus dexamethasone resulted in increased mortality. Treatment … the impact of pharmaceutical industry regulation and …
-
Human medicines European public assessment report (EPAR): Thalidomide Lipomed, thalidomide, Date of authorisation: 19/09/2022, Revision: 1, Status: Authorised
14 May 2024 18:28 GMT
… common side effects with Thalidomide Lipomed used together with … men and women taking the medicine.
Thalidomide Lipomed must never be … they are not pregnant before treatment and that they do … pregnant during or soon after treatment;
male patients who are …
-
Thalidomide survivors call on Govt to re-engage in talks
14 May 2024 15:16 GMT
… to include provisions for medical expenses.
Reacting to a … to include provisions for medical expenses.
Mr Donnelly … spokesperson for the Irish Thalidomide Association, said that … than 60-year thalidomide saga".
Thalidomide was withdrawn internationally …
-
Thalidomide Derivatives Show Promise Against Resistant Cancer Cells
14 May 2024 08:42 GMT
… than thalidomide. It was the central ingredient in a drug … past few decades, however, medicine has nevertheless pinned great … very effective in the treatment of multiple myeloma, malignant … from the Institute of Pharmaceutical Chemistry at Goethe University …